FR2480605A1 - Solutions concentrees stables de cisplastine dans un solvant et leur application pharmacologique - Google Patents

Solutions concentrees stables de cisplastine dans un solvant et leur application pharmacologique Download PDF

Info

Publication number
FR2480605A1
FR2480605A1 FR8105848A FR8105848A FR2480605A1 FR 2480605 A1 FR2480605 A1 FR 2480605A1 FR 8105848 A FR8105848 A FR 8105848A FR 8105848 A FR8105848 A FR 8105848A FR 2480605 A1 FR2480605 A1 FR 2480605A1
Authority
FR
France
Prior art keywords
cisplatin
solution
polyethylene glycol
molecular weight
sterile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8105848A
Other languages
English (en)
French (fr)
Other versions
FR2480605B1 (cs
Inventor
Murray Arthur Kaplan
Alphonse Peter Granatek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2480605A1 publication Critical patent/FR2480605A1/fr
Application granted granted Critical
Publication of FR2480605B1 publication Critical patent/FR2480605B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8105848A 1980-03-31 1981-03-24 Solutions concentrees stables de cisplastine dans un solvant et leur application pharmacologique Granted FR2480605A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
FR2480605A1 true FR2480605A1 (fr) 1981-10-23
FR2480605B1 FR2480605B1 (cs) 1984-05-11

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8105848A Granted FR2480605A1 (fr) 1980-03-31 1981-03-24 Solutions concentrees stables de cisplastine dans un solvant et leur application pharmacologique

Country Status (30)

Country Link
JP (1) JPS56152415A (cs)
KR (1) KR860000841B1 (cs)
AR (1) AR225500A1 (cs)
AT (1) AT370996B (cs)
AU (1) AU541056B2 (cs)
BE (1) BE888209A (cs)
CA (1) CA1162479A (cs)
CH (1) CH647481A5 (cs)
CS (1) CS246051B2 (cs)
DD (1) DD157762A5 (cs)
DE (1) DE3112272A1 (cs)
DK (1) DK158564C (cs)
ES (1) ES500869A0 (cs)
FI (1) FI70670C (cs)
FR (1) FR2480605A1 (cs)
GB (1) GB2074028B (cs)
GR (1) GR72769B (cs)
HU (1) HU183379B (cs)
IE (1) IE51070B1 (cs)
IL (1) IL62517A (cs)
IT (1) IT1170838B (cs)
LU (1) LU83270A1 (cs)
NL (1) NL8101531A (cs)
NO (1) NO156675C (cs)
NZ (1) NZ196519A (cs)
PH (1) PH17152A (cs)
PT (1) PT72774B (cs)
SE (1) SE455045B (cs)
SU (1) SU1056893A3 (cs)
ZA (1) ZA812084B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1980 *

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (cs) 1984-05-11
DE3112272C2 (cs) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (cs) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (cs) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
CA1152289A (en) Pharmaceutical compositions and process
CA2423825C (fr) Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2751875A1 (fr) Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2571966A1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
FR2480605A1 (fr) Solutions concentrees stables de cisplastine dans un solvant et leur application pharmacologique
JPS62145019A (ja) 抗炎症剤
CN102906110B (zh) 基于氯高铁血红素衍生物的抗微生物剂
CN105919931B (zh) 一种稳定的盐酸法舒地尔注射液及其制备方法
KR20170084107A (ko) 레바프라잔 염산염 다형체 및 그의 제조 방법
LU87102A1 (fr) Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel
NZ230127A (en) Cis-sulphato-trans-dichloro-1,1-bis(aminomethyl)cyclopentane-platinum-(iv) and pharmaceutical compositions
JPH04187618A (ja) 皮膚外用剤
CN111820406A (zh) 多肽白藜芦醇制剂及其制备方法和应用以及包含其的保健品或药物组合物
EP0021953A1 (fr) Solutions aqueuses stables d'alloxane
JPH09328425A (ja) アポトーシス調節剤
JPH0446144A (ja) トラネキサム酸エステル及び該エステルを有効成分とする抗色素沈着外用剤
RU2815979C1 (ru) Интраназальная композиция, содержащая соединения полидигидроксифенилентиосульфоната натрия (ПДФН) и L-триптофан, и способ получения композиции.
RU2313350C1 (ru) Способ повышения растворимости кальция сукцината, кальция малата и кальция цитрата для детских лекарственных форм
JPH05178716A (ja) アズレン誘導体
RU2112519C1 (ru) Способ извлечения бальнеологически активных компонентов для получения лекарственных средств
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
JPH09169652A (ja) 水性液状組成物
DK157484B (da) Fremgangsmaade til fremstilling af et cisplatin-praeparat
CA2537610A1 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof

Legal Events

Date Code Title Description
ST Notification of lapse